Global Rnai Drug Market PowerPoint PPT Presentations

The global market for RNAi drug delivery technologies reached nearly $9.3 billion in 2012 and nearly $11.7 billion in 2013. This market is expected to grow to $38.8 billion in 2018, with a compound annual growth rate(CAGR) of 27.2% from 2013 to 2018.

Epilepsy is a brain disorder characterized by spontaneously occurring and recurrent seizures. The market is heavily driven by the sales of antiepileptic drugs (AEDs) targeted at seizure reduction. The AED market is currently dominated by UCB’s Keppra and GlaxoSmithKline’s Lamictal. Although both drugs have experienced significant generic erosion, they form the mainstay of epilepsy treatment in the nine markets and will continue to have significant market share during the forecast period. See Full Report @ bit.ly/1vM6jVN

The report on Drug Discovery Technologies Market by technology type (biochips, high throughput screening, pharmacogenomics, genomics, bioanalytical instruments, bioinformatics, nanotechnology), end users (biopharmaceutical, pharmaceutical, research institutes and biotech companies) trends analysis and forecasts up to 2024 studies the market sizes, key trends and opportunities in the main geographies such as North America, Europe, Asia-Pacific, Rest of the World. According to the report the Global Drug Discovery Technologies Market is projected to grow at a CAGR of 18.4% in terms of value over the period of 2018-2024. The growth in the world market is primarily driven by significant contribution by North America (Leading region) region to this market.

The global RNA interference (RNAi) drug delivery market is expected to grow at a CAGR of 22.24% over the forecast period 2024-2032. Read more about our blog

Only one older generation drug with modest efficacy had been available until the recent arrival of two new therapies that could potentially change the prescribing landscape. Will these drugs make a significant impact on the Obesity market? Which drugs are used off-label for the treatment of obesity?

Migraine-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Migraine. Browse full report @ http://bit.ly/18hwGND

Meningitis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Meningitis. Browse full report @ http://bit.ly/1Af0SQT

Malaria-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Malaria. Browse full report @ http://bit.ly/1M2xkLX

Moderate Pain-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Moderate Pain. Browse full report @ http://bit.ly/19yaEYf

Metastatic Breast Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Breast Cancer. Browse full report @ http://bit.ly/1wgFgSu

Metastatic Pancreatic Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Pancreatic Cancer. Browse full report @ http://bit.ly/1N6x2Gb

Metastatic Ovarian Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Ovarian Cancer. Browse full report @ http://bit.ly/1Ls5dLa

Metastatic Colorectal Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Colorectal Cancer. Browse full report @ http://bit.ly/1aJpHP4

Metastatic Nonseminomatous Testicular Cancer-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2015, Report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the Metastatic Nonseminomatous Testicular Cancer. Browse full report @ http://bit.ly/1Mx6RXf

The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Metastatic Renal Cell Carcinoma Browse full report @ http://bit.ly/1CZ3W8C

The global temperature management market is estimated to grow at a CAGR of 2.4% from 2014 to 2019. Although mature markets such as the U.S., Germany, and U.K. hold larger shares in the temperature management market in 2014, the Asia-Pacific region is poised to grow at the highest CAGR of 3.4% in the next five years. The global temperature management market is highly competitive, with a large number of global and local players. See Full Report : http://bit.ly/ZXRBlm

Global drug discovery technologies market size is expected at $97.09 Bn by 2027 at a growth rate of 10.1% and growth analysis by The Business Research Company.

Global Orphan Drug Industry Analysis http://www.reportsnreports.com/reports/274449-global-orphan-drug-market-outlook-2018.html . The global pharmaceutical industry has been experiencing a slow growth in recent years owing to many factors such as expiration of patents, competition from generic drugs segment, exhausting pipelines, and an increasingly stringent regulatory framework. It is most likely that many blockbuster drugs would lose their exclusivity in the next 5 year horizon.

The Global RNA Based Therapeutic Market size is expected to reach $11.4 billion by 2027, rising at a market growth of 15.1 % CAGR during the forecast period.

Analysts forecast the Global Data Center Integrated Workload Systems market to grow at a CAGR of 49.16 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increase in big data. The Global Data Center Integrated Workload Systems market has also been witnessing the increased virtualization in network environments. However, the concerns regarding vendor lock-in could pose a challenge to the growth of this market. Global Data Center Integrated Workload Systems Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and the APAC regions; it also covers the Global Data Center Integrated Workload Systems market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Cancers, and several other malignant diseases have been the centre of research interests worldwide over the past few decades. The advent of genome engineering has further facilitated the application of gene transplant technique in disease management in case of these conditions.

RNA Based Therapeutics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $1.2 billion by 2020, registering a CAGR of 28.4% during the period 2014-2020.Due to its ability to render targeted solutions for chronic diseases such as cancer, AIDS, rare genetic disorders, and certain cardiovascular conditions, RNA based therapeutics is expected to significantly impact the global pharmaceutical industry.

Antisense and RNAi therapeutics market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market is growing at a healthy CAGR in the above-mentioned research forecast period. Rising prevalence of the genetic diseases, neurological disorders and advancement in the biotechnological sector are the factors responsible for the growth of this market.

The report covers the analysis of global as well as regional markets of Drug Discovery Technologies. Moreover, the report gives insights into the factors that affect the global as well as regional performance of the market in the short run and in the long run.

“Market Snapshot: Mammography Systems 2006 to 2020 - Americas (US, Canada, Brazil, Mexico)” provides quantitative analysis of the two mammography systems market segments: full field mammography systems and film-screen mammography systems. See Full Report @ bit.ly/1tYAebh

This report, the Global RNAi Drug Delivery Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global RNAi Drug Delivery market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

RNA based therapeutics has garnered significant attention in the recent years due to its potential to treat variety of chronic diseases such as cancer, diabetes, AIDS, Tuberculosis and certain cardiovascular conditions. Despite being in the clinical research phase, the RNA based therapeutics is been explored as a promising treatment option for the diseases which are difficult to treat. Detailed report at: http://www.reportsandintelligence.com/RNA-based-therapeutics-market

“2014 Strategies for the Global Drugs of Abuse Testing Market” is a unique study designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study explores future trends in the U.S., five major European countries and Japan; and provides test volume and sales forecasts by country, market segment and individual .

The report "RNA Analysis/Transcriptomics Market by Technology (Microarray, PCR, NGS, RNAi), by Application (Clinical Diagnostics, Drug Discovery, Toxicogenomics), by End-User (Academic Research, Pharmaceutical and Biotech Companies) - Global Forecast to 2019" The global transcriptomics market is estimated to be worth $1985.5 million by the end of 2014 and is expected to reach $3,773.0 million by 2019, at a CAGR of 13.7% from 2014 to 2019.

Global RNA Interference Therapy Industry Analysis http://www.reportsnreports.com/reports/276765-global-rna-interference-rnai-therapy-market-outlook-2018.html . The popularity of RNAi technology has been increasing in recent times as is has become a major component of basic research, and in drug discovery. Over the years this technology has become an integral part of the process of determining the functions of gene, in analyzing pathways, and in the validation of the target both in academia and in industry.

Antibody-Drug Conjugate: Global Market and Pipeline Outlook, 2015, report provides the information across the ADCs drug value chain. The Report provides the marketed and pipeline scenario of the ADCs. Browse full report @ http://bit.ly/19p5nBl

Analysts forecast the Global Drug-eluting Stent (DES) market to grow at a CAGR of 5.79 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increasing prevalence of CVD. The Global Drug-eluting Stent (DES) market has also been witnessing the increasing demand for minimally invasive procedures. However, the decline in the average selling price of drug eluting stents could pose a challenge to the growth of this market. Global Drug-eluting Stent (DES) Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Drug Eluting Stent market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The global biopharmaceuticals contract manufacturing market size is expected to reach USD 21.7 billion by 2025

Global Antisense and RNAi Therapeutics Market is Segmentation by Technology & Therapeutics Area. Global Antisense and RNAi Therapeutics Market 2015-2019 report define Buying Criteria, Pipeline Snapshot & Market Growth Drivers. Report analyzes financial performance of Key Vendor & recent developments. Complete report is spread across 70 pages and available @ http://www.reportsnreports.com/reports/316393-global-antisense-and-rnai-therapeutics-market-2015-2019.html. Analysts forecast the Global Antisense and RNAi Therapeutics market to grow at a CAGR of 26.79 percent over the period 2014-2019.

According to the latest research report by IMARC Group, The South Korea biologics market size is projected to exhibit a growth rate (CAGR) of 7.06% during 2024-2032. More Info:- https://www.imarcgroup.com/south-korea-biologics-market

Aarkstore.com announces, The Latest market research report is available in its vast collection "Ophthalmic Drugs; Data, Analysis and Forecasts to 2024" For More Details : http://goo.gl/bj1WK7

Get a sample brochure @ http://tinyurl.com/zhbq245 North America is the leading region in the MiRNA Market due to the high investment in the pharmaceuticals industry and research industry and for the development of the miRNA therapeutic products. The conditions like cancer can also be treated using the microRNA technology. Europe is expected to witness high demand for the MiRNA Market due to the increasing elderly population and high used of medical assistance for various illnesses. The pharmaceutical industry is strongly researching for various medications for fatal illnesses using miRNA assay and miRNA gene of humans.

The global gene expression analysis market witnesses high competitive intensity as there are many big and small firms with similar product offerings. These companies adopt various strategies (innovations, acquisitions, and geographic expansions related to endoscopy products) to increase their market shares and to establish a strong foothold in the global market. Complete report available @ http://www.rnrmarketresearch.com/gene-expression-analysis-market-by-technology-dna-microarray-real-time-pcr-next-generation-sequencing-consumables-dna-chips-reagents-services-gene-profiling-bioinformatics-data-analysis-market-report.html .

Read here the market research report published by CMI team.

The Co-Evolution of Science, Technology and Strategy in Everyday Practice: ... Cellular and Molecular Pharmacology. In vitro drug activity. Cellular Disease Models ...

Gene Therapy Respiratory Insight: Pipeline Assessment, Market Trend, Technology and Competitive Landscape” provides in depth insights into the Respiratory gene therapy. It has covered 5+ gene therapies covering 5+ Pharmaceutical companies. View Complete Report @ http://www.rnrmarketresearch.com/gene-therapy-respiratory-insight-pipeline-assessment-market-trend-technology-and-competitive-landscape-market-report.html

Gene Therapy Oncology Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. View Complete Report @ http://www.rnrmarketresearch.com/gene-therapy-oncology-insight-pipeline-assessment-market-trend-technology-and-competitive-landscape-market-report.html

Gene Therapy Gastrointestinal Insight: Pipeline Assessment, Technology Trend, and Competitive Landscape provides the information across the gene therapy value chain covering gene therapy profiles core insights, pre-clinical data, clinical data, technology details, funding and licensing opportunities. View Complete Report @ http://www.rnrmarketresearch.com/gene-therapy-gastrointestinal-insight-pipeline-assessment-market-trend-technology-and-competitive-landscape-market-report.html

The scope of the report is to highlight and gauge existing technologies in the production of therapeutic mAbs. The report also discusses key insights on interchangeability and substitution of therapeutic antibodies and biosimilars.

* * * * * * 4 * * ...

One of the most important lessons to emerge is that biotechnology is a hard slog. ... Having already confessed to being a fool...a more preposterous thought: ...

Title: Main title Author: admin Last modified by: risc116 Document presentation format: On-screen Show Other titles: Arial Constantia Calibri Wingdings PMingLiU ...

Treatments limited by toxicity Temezolomide (TMZ) effectively treats disease. but prolonged TMZ treatment results in severe lymphopenia and thrombocytopenia death ...

Alnylam Pharmaceuticals. Cambridge, MA. Today's Objectives ... Many players competing in the arena with no one player emerging as leader. Many Companies ...

Specialist unit within NZ Trade and Enterprise. Team of 40 professionals ... shark cartilage, abolone powder, pacific oyster powder, shark liver oil, omega 3 ...

Wedded to first concept of company (most change focus in 3 years) ... Laureen Higgens BD Biosciences (SoAm) www.bd.com. Helen Cunniff BD Biosciences (Asia) www.bd.com ...

Sterling-Winthrop Kodak=Sanofi Syntholobo=Sanofi-Syntholobo ... www.clinicaltrials.gov. 14 October 2004. Placet Research. 18. Summary ...

STAVCON 2003

xap:CreatorTool Adobe Photoshop CS2 Windows /xap:CreatorTool ... photoshop:ICCProfile sRGB IEC61966-2.1 /photoshop:ICCProfile photoshop:History ...

Merck: What we Look for in a Licensing Partner Susan Rohrer, PhD Senior Director Licensing & External Research Merck Research Laboratories ASENT Annual Meeting

hERG Screening Market research report presents an in depth analysis of hERG Screening market. The study emphasizes on both technology and product segments of hERG Screening in biotechnology and pharmaceutical application areas. For More Details: http://goo.gl/ddgMuV